Common Questions & Answers
A person can acquire hepatitis C when they come into contact with blood that carries the virus. This often occurs by sharing needles or other drug paraphernalia. Unsterile tattoo needles, shared personal hygiene items, and unprotected sex can also transmit hepatitis C.
Hepatitis C is often curable by taking antivirals early to prevent complications. Up to 20 percent of people with acute hepatitis C clear the virus without treatment in six months — however, hepatitis C often becomes chronic and causes complications if it’s not treated.
Many people with hepatitis C have no symptoms, while others may experience fatigue, nausea and vomiting, dark urine, fever, joint or muscle pain, and jaundice. Symptoms can take years to develop. Screening can rule out hepatitis C in those without symptoms.
Healthcare professionals diagnose hepatitis C with blood tests that detect the virus. Consider hepatitis C testing if you have a history of injecting drugs, are pregnant, live with HIV, or have other risk factors for exposure.
Avoid sharing needles or other drug paraphernalia, practice safe sex or avoid sexual contact with people who have hepatitis C, and if you get any tattoos or piercings, only do so at regulated facilities that sterilize their equipment. There is no vaccine to prevent hepatitis C.
Jonathan G. Stine, MD, MSc, FACP
Medical Reviewer
Jonathan Stine, MD, MSc, FACP, is an associate professor of medicine and public health science at Penn State in State College, Pennsylvania.
As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction–associated steatotic liver disease (MASLD) and exercise, he has authored more than 100 peer-reviewed papers, including multinational consensus guidelines.
Dr. Stine is the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases and the American Cancer Society, and has maintained continuous funding from the National Institutes of Health since 2018.
Stine is the MASLD consultant to the American College of Sports Medicine’s “Exercise is Medicine” initiative, and recently co-chaired the International Roundtable on MASLD and Physical Activity for ACSM. He serves as the Fatty Liver Program director as well as the Liver Center Research director for Penn State.
- Hepatitis C. Mayo Clinic. August 23, 2023.
- Hepatitis C. National Institute of Diabetes and Digestive and Kidney Diseases.